← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $990K of Moderna, Inc.

Sold$989,646
$98.96Price
10,000Shares

What MRNA did after the filing

Filed Sep 29Copier in Oct 2
The stock from Mon, Oct 2 open, $103.12
−31.9%
S&P 500, same days
+3.2%

Measured over 30 trading days, to the Nov 13 close.

Traded Wed, Sep 27. Filed Fri, Sep 29, 7:00 PM ET, after the close. Returns use the Oct 2 open and the Nov 13 close. Not investment advice.